Aldagen, Inc., a pioneering biotechnology firm headquartered in the United States, is at the forefront of regenerative medicine. Founded in 2007, the company has made significant strides in developing innovative cell therapies, particularly focusing on the unique properties of adult stem cells. With operational regions extending across North America, Aldagen is dedicated to advancing treatments for various degenerative diseases and injuries. The company’s core offerings include proprietary stem cell products that harness the regenerative potential of adult stem cells, setting them apart in the competitive landscape of the biotechnology industry. Aldagen's commitment to scientific excellence and patient-centric solutions has positioned it as a leader in the field, with notable achievements in clinical research and partnerships that enhance its market presence.
We don't have data for Aldagen, Inc., but we can show you information about their parent organization instead.
View parent company